Latest Breaking News On - Mark sulkowski - Page 1 : vimarsana.com

The Future and Resources in HCV Care

Expert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.

Practical Implementation of HCV Care

The panelists offer practical tips on implementing HCV care into your clinical practice.

From NAFLD to MASLD: 2023 Brings New Liver Disease Nomenclature

Following years of concerns about the stigmatization and inaccurate etiology of nonalcoholic fatty liver disease nomenclature, 2023 finally saw revised terminology for liver disease with the implementation of metabolic dysfunction-associated steatotic liver disease.

Adherence and HCV Treatment

The panelists discuss adherence in HCV treatment.

Monitoring Treatment and Confirming the Cure of HCV

Experts in HCV care discuss monitoring HCV treatment.

Treatment Options for HCV

An overview of treatment regimens for HCV.

Candidates for HCV Treatment

Expert hepatologist Mark Sulkowski, MD discusses which patients are candidates for HCV treatment.

The Hepatitis C Elimination Goal

Experts discuss where we currently stand on the World Health Organization elimination goals for Hepatitis C virus.

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data